Matches in SemOpenAlex for { <https://semopenalex.org/work/W2983708577> ?p ?o ?g. }
- W2983708577 endingPage "103581" @default.
- W2983708577 startingPage "103581" @default.
- W2983708577 abstract "Nowadays, there are no targeted therapeutic modalities for triple negative breast cancer (TNBC). This disease is associated with poor prognosis and worst clinical outcome because of the aggressive nature of the tumor, delayed diagnosis, and non-specific symptoms in the early stages. Therefore, identification of novel specific TNBC serum biomarkers for screening and therapeutic purposes remains an urgent clinical requirement. New user-friendly and cheap methods for biomarker identification are needed, and nanotechnology offers new opportunities. When dispersed in blood, nanoparticles (NPs) are covered by a protein shell termed “protein corona” (PC). While alterations in protein patterns are challeging to detect by conventional blood analyses, PC acts as a “nano-concentrator” of serum proteins with affinity for NPs’ surface. So, the characterization of PC could allow the detection of otherwise undetectable changes in protein concentration at an early stage of the disease or after chemotherapy or surgery. To explore this research idea, serum samples from 8 triple negative breast cancer (TNBC) patients and 8 patients without malignancy were allowed to interact with gold nanoparticles (AuNPs: 10.02 ± 0.91 nm), silver nanoparticles (AgNPs: 9.73 ± 1.70 nm) and magnetic nanoparticles (MNPs: (9.30 ± 0.67 nm). Here, in order to identify biomarker candidates in serum of TNBC patients, these nanomaterials were combined with electrophoretic separation (SDS-PAGE) to performed qualitative and quantitative comparisons of the serum proteomes of TNBC patients (n = 8) and healthy controls (n = 8) by liquid chromatography tandem-mass spectrometry (LC-MS/MS) analysis. The results were validated through a sequential window acquisition of all theoretical mass spectra (SWATH) analysis, performed in total serum samples (patients and controls) using this approach as a multiple reaction monitoring (MRM) analysis. It is well known that several proteins presented in human serum are important biomarkers for the diagnosis or prognosis of different diseases, as triple negative breast cancer (TNBC). Determining how nanomaterials as gold nanoparticles (AuNPs: 10.02 ± 0.91 nm), silver nanoparticles (AgNPs: 9.73 ± 1.70 nm) and magnetic nanoparticles (MNPs: (9.30 ± 0.67 nm) interact with human serum will assist not only in understanding their effects on the biological system (biocompability and toxicity), but also to obtain information for developing novel nanomaterials with high specificity and selectivity towards proteins with an important biological function (prognostic and diagnostic protein biomarkers)." @default.
- W2983708577 created "2019-11-22" @default.
- W2983708577 creator A5010902784 @default.
- W2983708577 creator A5012063762 @default.
- W2983708577 creator A5016085265 @default.
- W2983708577 creator A5025936291 @default.
- W2983708577 creator A5038022963 @default.
- W2983708577 creator A5046954813 @default.
- W2983708577 creator A5050742607 @default.
- W2983708577 creator A5061802540 @default.
- W2983708577 creator A5067495811 @default.
- W2983708577 date "2020-02-01" @default.
- W2983708577 modified "2023-10-17" @default.
- W2983708577 title "Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers" @default.
- W2983708577 cites W1963565300 @default.
- W2983708577 cites W1971273911 @default.
- W2983708577 cites W1973831032 @default.
- W2983708577 cites W1975329691 @default.
- W2983708577 cites W1977000581 @default.
- W2983708577 cites W1987918943 @default.
- W2983708577 cites W1988983477 @default.
- W2983708577 cites W1989090339 @default.
- W2983708577 cites W1993457485 @default.
- W2983708577 cites W2004604974 @default.
- W2983708577 cites W2005334224 @default.
- W2983708577 cites W2015509667 @default.
- W2983708577 cites W2017798883 @default.
- W2983708577 cites W2021230254 @default.
- W2983708577 cites W2024590154 @default.
- W2983708577 cites W2027239458 @default.
- W2983708577 cites W2033084806 @default.
- W2983708577 cites W2038246612 @default.
- W2983708577 cites W2046726975 @default.
- W2983708577 cites W2053749578 @default.
- W2983708577 cites W2054834955 @default.
- W2983708577 cites W2060754367 @default.
- W2983708577 cites W2061601119 @default.
- W2983708577 cites W2064067686 @default.
- W2983708577 cites W2069860553 @default.
- W2983708577 cites W2082318061 @default.
- W2983708577 cites W2084287411 @default.
- W2983708577 cites W2084871302 @default.
- W2983708577 cites W2094229819 @default.
- W2983708577 cites W2106787323 @default.
- W2983708577 cites W2115129497 @default.
- W2983708577 cites W2122017226 @default.
- W2983708577 cites W2123929534 @default.
- W2983708577 cites W2128985829 @default.
- W2983708577 cites W2162793920 @default.
- W2983708577 cites W2166869160 @default.
- W2983708577 cites W2168193025 @default.
- W2983708577 cites W2169109415 @default.
- W2983708577 cites W2276751188 @default.
- W2983708577 cites W2310953578 @default.
- W2983708577 cites W2331854437 @default.
- W2983708577 cites W2464324664 @default.
- W2983708577 cites W2556739841 @default.
- W2983708577 cites W2564788625 @default.
- W2983708577 cites W2580539133 @default.
- W2983708577 cites W2599830752 @default.
- W2983708577 cites W2610156696 @default.
- W2983708577 cites W2611694733 @default.
- W2983708577 cites W2738153741 @default.
- W2983708577 cites W2770646498 @default.
- W2983708577 cites W2772824299 @default.
- W2983708577 cites W2782456575 @default.
- W2983708577 cites W2794427287 @default.
- W2983708577 cites W2802893622 @default.
- W2983708577 cites W2887294942 @default.
- W2983708577 cites W2906894504 @default.
- W2983708577 cites W2911243239 @default.
- W2983708577 cites W2947848987 @default.
- W2983708577 cites W2950647505 @default.
- W2983708577 cites W4256403835 @default.
- W2983708577 doi "https://doi.org/10.1016/j.jprot.2019.103581" @default.
- W2983708577 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31731051" @default.
- W2983708577 hasPublicationYear "2020" @default.
- W2983708577 type Work @default.
- W2983708577 sameAs 2983708577 @default.
- W2983708577 citedByCount "39" @default.
- W2983708577 countsByYear W29837085772020 @default.
- W2983708577 countsByYear W29837085772021 @default.
- W2983708577 countsByYear W29837085772022 @default.
- W2983708577 countsByYear W29837085772023 @default.
- W2983708577 crossrefType "journal-article" @default.
- W2983708577 hasAuthorship W2983708577A5010902784 @default.
- W2983708577 hasAuthorship W2983708577A5012063762 @default.
- W2983708577 hasAuthorship W2983708577A5016085265 @default.
- W2983708577 hasAuthorship W2983708577A5025936291 @default.
- W2983708577 hasAuthorship W2983708577A5038022963 @default.
- W2983708577 hasAuthorship W2983708577A5046954813 @default.
- W2983708577 hasAuthorship W2983708577A5050742607 @default.
- W2983708577 hasAuthorship W2983708577A5061802540 @default.
- W2983708577 hasAuthorship W2983708577A5067495811 @default.
- W2983708577 hasBestOaLocation W29837085772 @default.
- W2983708577 hasConcept C104317684 @default.
- W2983708577 hasConcept C104397665 @default.
- W2983708577 hasConcept C121608353 @default.